💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Insmed, Inc. (INSM)
« Back to company indexINSM Chatter Timeline
Stock Ticker for INSM
Most Active Tweeters for INSM
| User | Tweets |
|---|---|
| @InsiderAlerts4U | 7 |
| @FlashAlert_me | 4 |
| @Tickeron | 4 |
| @JFDI | 3 |
| @stockmktgenius | 3 |
Recent Tweets for INSM
 |
@EZMoney_41 $INSM Trading is easy with Buy and Short signals in real time. https://t.co/hBQhNoaBYh January 20th 2021, 1:01am |
 |
@SeekingAlpha $INSM - Insmed (INSM) Presents At 39th Annual J.P. Morgan Healthcare Conference - Slideshow.… https://t.co/npGIYzz7tO January 19th 2021, 9:01pm |
 |
@JFDI $INSM taking out pivot. January 19th 2021, 2:01pm |
 |
@stockhoot $INSM Credit Suisse Maintains to Outperform : PT $60.00 https://t.co/Oqj9MYDiPx January 19th 2021, 1:01pm |
 |
@stockmktgenius $INSM Insmed, Inc. - Common Sto #LeaderPullBack Close: 36.24 Liq: $25M https://t.co/gk9jXLC3QR January 19th 2021, 10:01am |
|
@stockmktgenius $INSM Insmed, Inc. - Common Sto #LeaderPullBack Close: 37.37 Liq: $24M https://t.co/gk9jXLC3QR January 15th 2021, 3:01pm |
|
@stockmktgenius $INSM Insmed, Inc. - Common Sto #LeaderPullBack Close: 36.38 Liq: $64M https://t.co/gk9jXLC3QR January 14th 2021, 11:01am |
 |
@dy2ski @bradloncar $INSM Insmed. Under the radar but very solid achievements and very bullish timeline. January 13th 2021, 10:01pm |
 |
@bioILLOGICAL Nice move here for $INSM, one of my take-home-to-meet-mom biotechs you'd wanna marry and hold for the long term picks. #meetmombiotechs January 12th 2021, 3:01pm |
 |
@LongStonks @adamfeuerstein They should buy $INSM - has a solid commercial product with an expanding label and an even more imp… https://t.co/OodeSMcdLk January 11th 2021, 8:01pm |
 |
@DataswarmM $INSM We have detected a noticeable fall in the Zeitgeist for Insmed Inc at https://t.co/39ETgZ3bxw Visit DataSwar… https://t.co/BORIdAyAwL January 11th 2021, 1:01pm |
 |
@laurenarabanoo RT @Tickeron: $INSM enters a Downtrend as Momentum Indicator dropped below the 0 level on December 16, 2020. View odds for this and other i… January 11th 2021, 1:01pm |
 |
@Tickeron $INSM enters a Downtrend as Momentum Indicator dropped below the 0 level on December 16, 2020. View odds for this a… https://t.co/8bXekR5kZH January 11th 2021, 1:01pm |
 |
@StockTexts $INSM Insmed, Inc. SEC Filing: Form 8-K https://t.co/DF9fQIYMnk January 11th 2021, 11:01am |
 |
@EdgarInsider Filing Alert, FORM 8-K [Press/News Current Report] available. $INSM INSMED Inc https://t.co/JL0vy5IRKE January 11th 2021, 11:01am |
 |
@fintel_io Also, if you are new to $INSM here's a background article on Finpedia for you https://t.co/EPfcybVU8t January 11th 2021, 11:01am |
|
@fintel_io $INSM / Insmed files form 8-K - Regulation FD Disclosure, Financial Statements and Exhibits - FORM 8-K https://t.co/gusNq67vwB January 11th 2021, 11:01am |
 |
@FlashAlert_me $INSM [15s. delayed] filed form 8-K on January 11, 06:31:07: Item7.01: Regulation FD https://t.co/aiuv14A05m January 11th 2021, 11:01am |
 |
@wisetrashpanda $INSM Backtesting previous resistance and uptrend line. https://t.co/q5C1kblro9 January 10th 2021, 2:01am |
 |
@InsiderAlerts4U $INSM: New Insider Filing on INSMED Inc's Chief Commercial Officer ROGER ADSETT: https://t.co/leP5KoYvJS January 9th 2021, 9:01am |
|
@InsiderAlerts4U $INSM: New Insider Filing on INSMED Inc's Chief Financial Officer SARA BONSTEIN: https://t.co/jwQxvyKAn0 January 9th 2021, 8:01am |
|
@InsiderAlerts4U $INSM: New Insider Filing on INSMED Inc's Chief Compliance Officer JOHN SORIANO: https://t.co/hMrpMcXwYG January 9th 2021, 7:01am |
|
@InsiderAlerts4U $INSM: New Insider Filing on INSMED Inc's Chief Medical Officer MARTINA M.D. FLAMMER: https://t.co/AZz0fG6pot January 9th 2021, 5:01am |
|
@InsiderAlerts4U $INSM: New Insider Filing on INSMED Inc's Chief People Strategy Officer ORLOV S NICOLE SCHAEFFER: https://t.co/xEioj0k0wg January 8th 2021, 11:01pm |
|
@InsiderAlerts4U $INSM: New Insider Filing on INSMED Inc's Chair & CEO WILLIAM LEWIS: https://t.co/QXKlWdic2F January 8th 2021, 10:01pm |
|
@InsiderAlerts4U $INSM: New Insider Filing on INSMED Inc's Chief Legal Officer CHRISTINE A PELLIZZARI: https://t.co/eojDrUWie9 January 8th 2021, 5:01pm |
|
@StockTexts $INSM Insmed, Inc. SEC Filing: Form 4 https://t.co/DEIqgc1uWg January 8th 2021, 4:01pm |
|
@Tickeron $INSM's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for th… https://t.co/zp9sQ5YbgF January 8th 2021, 12:01pm |
|
@JFDI $INSM sitting on 30wk line and weekly b/o. just watching for now January 8th 2021, 11:01am |
|
@Tickeron $INSM's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for th… https://t.co/g94iemSnOi January 7th 2021, 9:01am |
 |
@mediasentiment $INSM new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 352 January 7th 2021, 7:01am |
|
@mediasentiment $INSM new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 351 January 7th 2021, 7:01am |
|
@FlashAlert_me $INSM [15s. delayed] filed SEC form 4: Chief Medical Officer Flammer Martina M.D.: Delivered securities 949 of Com… https://t.co/4cMHyfEkKg January 6th 2021, 5:01pm |
|
@FlashAlert_me $INSM [15s. delayed] filed SEC form 4: Chief Commercial Officer Adsett Roger: Delivered securities 5,188 of Common… https://t.co/InGvDOMUzw January 6th 2021, 5:01pm |
|
@FlashAlert_me $INSM [15s. delayed] filed SEC form 4: Chair & CEO Lewis William: Transacted Derivative Securities between 2020-12… https://t.co/H5M50bF7m7 January 6th 2021, 5:01pm |
|
@JFDI Monthly range. $INSM - #INSM chart https://t.co/PK2QCeSSES January 6th 2021, 9:01am |
 |
@MoneyMakin_Mire RT @Tickeron: $INSM in Uptrend: price may ascend as a result of having broken its lower Bollinger Band on December 16, 2020. View odds for… January 6th 2021, 5:01am |
|
@Tickeron $INSM in Uptrend: price may ascend as a result of having broken its lower Bollinger Band on December 16, 2020. View… https://t.co/xg3gSXLHcm January 6th 2021, 5:01am |
 |
@1stOncology #Insmed to Present at the 39th Annual #JPMorgan #HealthcareConference $INSM https://t.co/g3sRuThNZ9 January 6th 2021, 4:01am |
 |
@newsfilterio Insmed to Present at the 39th Annual J.P. Morgan Healthcare Conference $INSM https://t.co/KZpNqBUpFM January 6th 2021, 2:01am |
 |
@MarketBattler Wow that is why we need to respect risk. Haven't had one like this in a while but $INSM came close. I got stopped… https://t.co/P5PFweEQBV January 5th 2021, 2:01pm |
 |
@Allstocknews $INSM Insmed to Present at the 39th Annual J.P. Morgan Healthcare Conference From our Stock News Alerts App January 5th 2021, 8:01am |
 |
@stock_titan $INSM Insmed to Present at the 39th Annual J.P. Morgan Healthcare Conference https://t.co/BpbCATZPW2 January 5th 2021, 8:01am |
|
@newsfilterio Insmed Initiates Frontline Clinical Trial Program for ARIKAYCE® in Patients with MAC Lung Disease $INSM https://t.co/XUCGodXquU January 5th 2021, 12:01am |
|
@newsfilterio Insmed initiates frontline trial program for Arikayce in MAC lung disease $INSM https://t.co/YYGtyIZPZI January 4th 2021, 2:01pm |
 |
@MarketCurrents $INSM - Insmed initiates frontline trial program for Arikayce in MAC lung disease https://t.co/eUl48o7dyF January 4th 2021, 2:01pm |
 |
@sbwcws Insmed initiates frontline clinical trial program for ARIKAYCE $INSM January 4th 2021, 8:01am |
|
@Allstocknews $INSM Insmed Initiates Frontline Clinical Trial Program for ARIKAYCE® (amikacin liposome inhalation suspensio From our Stock News Alerts App January 4th 2021, 8:01am |
|
@stock_titan $INSM Insmed Initiates Frontline Clinical Trial Program for ARIKAYCE® (amikacin liposome inhalation suspension) in… https://t.co/r7HPuN9teT January 4th 2021, 8:01am |
 |
@TheStockWire $INSM SVB Leerink Maintains Outperform on Insmed, Raises Price Target to $55 January 4th 2021, 4:01am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
Get the DrugPatentWatch Daily Briefing
Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
- ✓ Patent Expirations and Generic Entry
- ✓ 505(b)(2) & Biosimilars
- ✓ Insightful Articles and Case Studies
- ✓ Patent Litigation & Challenges
- ✓ Industry Trends
